Surgical | Ophthalmology Innovation Source

ClarVista Medical HARMONI Offers “Elegant Simplicity”

ClarVista Medical is a clinical-stage ophthalmic company that is introducing the HARMONI Modular IOL system to help surgeons navigate “the increasingly demanding environment of cataract surgery,” CEO Paul McLean said. Intraocular lens (IOL) design has not undergone a fundamental change in decades, but that’s about to change, he promised. “Until we can solve the dilemma…

Yeu on the Success of the Spotlight on the Premium Channel

Elizabeth Yeu, MD, led the “Spotlight on the Premium Channel” discussion at OIS@ASCRS 2016. In her session, representatives from AcuFocus, Bausch + Lomb, Abbott Medical Optics and Alcon shared information about their current and future pipelines. Dr. Yeu serves as a Corneal, Cataract and Refractive Surgeon at Virginia Eye Consultant and dedicates her time to…

Ivantis Goes After Canal-based MIGS

Ivantis was founded in 2007 by two coronary stent inventors to develop “the only minimally invasive microstent for glaucoma that dilates and scaffolds Schlemm’s canal.” With 25 full-time employees, the company has raised $102 million, and closed a $71 million B round last year, said Dave van Meter, president and CEO. More than 2,500 patients…

Transcend Medical

Refocus VIS Requires No Compromise

Refocus Group’s goal, according to CEO Mike Judy, is to become the preferred surgical alternative for the treatment of presbyopia. The VisAbility Implant System (VIS) is a “simplified procedure that delivers secure, uncomplicated, and consistent placement of the scleral implants,” he said. “This platform offers the only presbyopic solution that provides a full range of…

PowerVision Shows `True Accommodation’

PowerVision has developed a fluid-controlled accommodating intraocular lens (IOL), the FluidVision AIOL, as the first platform to provide “true accommodation” by mimicking the eye’s natural accommodative process to transport fluids inside it, creating true shape change. “This is the first true shape-changing IOL system,” president, CEO, and co-founder Barry Cheskin said, and 36-month results are…

Glaukos Recounts IPO Roadshow

Glaukos completed its IPO on June 25, 2015, but the road getting there was a long one. Before going public, the company that was founded in 2001 raised more than $150 million of enterprise capital in six rounds of financing. It was the first to enter into the micro-invasive glaucoma surgery (MIGS) space, and began…

Frinzi Shares a Bit of His Plans for AMO

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 079″] Following his successful exit from WaveTec, Tom Frinzi joined Abbott as a senior vice president and head of AMO. In this exclusive interview with OIS, Frinzi shares his motivations and what he’d like to see AMO become. 10 Top Topics in this OIS Podcast: Ophthalmology is in his DNA. Spent…

Lewis Handicaps MIGS Market & Explains Glaucoma’s Emergence

Lewis Handicaps MIGS Market and Explains Glaucoma’s Emergence - OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 077″] Glaucoma specialist Dr. Richard Lewis says glaucoma was once the “boring step sister” of the ophthalmology world. But now the chief medical officer of Aerie says the rise in devices and drugs has made glaucoma one of the coolest kids in ophthalmology’s school yard. 10 Top Topics in this OIS…

Orca Aggressively Pursues Cataract Surgery Market

Yariv Bar-On, CEO of Orca Surgical, explains how his company is trying to change how surgeons remove the corneal epithelium during ophthalmic laser surgery. Orca says its flagship Epi Clear dynamic epikeratome device will introduce a “new paradigm for laser-assisted refractive surgery that is safer and less painful than existing microkeratome flap keratomileusis and advanced…

IOPtima Getting Traction in Europe, Asia

IOPtima CEO Ronan Castro gives OISTV an update on the company’s commerical launch of the IOPtimate system in Europe and Asia, including operations in China and Hong Kong. OPtima has developed the IOPtimate system; a unique laser based surgical system for the treatment of Glaucoma. The system utilizes a CO2 laser technology to reduce internal…

OIS Innovation Award Presentation

This video honors Tom Frinzi and Dan Durrie, MD, for their successful leadership at WaveTec. Recipients: Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. Prior to joining Abbott, Mr. Frinzi held a number…